These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6340634)

  • 21. Correlation between plasma cortisol and CSF catecholamines in endogenous depressed dexamethasone nonsuppressors.
    Lu RB; Ho SL; Ho BT; Leu SY; Shian LR; Chen WL
    J Affect Disord; 1986; 10(3):177-84. PubMed ID: 2943770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexamethasone suppression test and TRH test in endogenous depression.
    Aggernaes H; Kirkegaard C; Krog-Meyer I; Kijne B; Larsen JK; Laursen AL; Lykke-Olesen L; Mikkelsen PL; Rasmussen S; Bjørum N
    Acta Psychiatr Scand; 1983 Apr; 67(4):258-64. PubMed ID: 6407280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of antidepressant withdrawal on the dexamethasone suppression test.
    Dilsaver SC; Greden JF
    Psychiatry Res; 1985 Feb; 14(2):11-22. PubMed ID: 3857651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F; Haack D; Gerken A; Vecsei P
    Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug.
    Wiedemann K; Holsboer F
    Biol Psychiatry; 1987 Nov; 22(11):1340-8. PubMed ID: 3663786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The usefulness of DST in predicting response to antidepressants: a placebo-controlled study.
    Georgotas A; Stokes P; McCue RE; Dubow A; Welkowitz J; Friedman E; Fanelli C; Chang I; Cooper TB
    J Affect Disord; 1986; 11(1):21-8. PubMed ID: 2944924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dexamethasone suppression test and treatment outcome in elderly depressed patients participating in a placebo-controlled multicenter trial involving moclobemide and nortriptyline.
    Kin NM; Nair NP; Amin M; Schwartz G; Ahmed SK; Holm P; Katona C; Kragh-Sorensen P; Klitgaard N; Song WY; West TE; Stage K
    Biol Psychiatry; 1997 Nov; 42(10):925-31. PubMed ID: 9359979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the introduction of the dexamethasone suppression test on diagnosis and treatment of depression by psychiatrists.
    Schrader GD; Durbridge TC
    Aust N Z J Psychiatry; 1983 Dec; 17(4):350-3. PubMed ID: 6581793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dexamethasone suppression test and unipolar/bipolar distinctions.
    Zisook S; Janowsky DS; Overall JE; Risch SC
    J Clin Psychiatry; 1985 Nov; 46(11):461-5. PubMed ID: 4055705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Major depression in the elderly: DSM-III criteria and the dexamethasone suppression test as predictors of treatment response.
    Spar JE; La Rue A
    Am J Psychiatry; 1983 Jul; 140(7):844-7. PubMed ID: 6859297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dexamethasone suppression test as a predictor of sleep deprivation antidepressant effect.
    King D; Dowdy S; Jack R; Gardner R; Edwards P
    Psychiatry Res; 1982 Aug; 7(1):93-9. PubMed ID: 6957903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated dexamethasone suppression test in major depression.
    Hellebuyck H; Maes M; Suy E
    Acta Psychiatr Belg; 1988; 88(5-6):378-86. PubMed ID: 3079168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression.
    Greden JF; Albala AA; Haskett RF; James NM; Goodman L; Steiner M; Carroll BJ
    Biol Psychiatry; 1980 Jun; 15(3):449-58. PubMed ID: 7378518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Informed use of the dexamethasone suppression test.
    Carroll BJ
    J Clin Psychiatry; 1986 Jan; 47(1 Suppl):10-2. PubMed ID: 3941065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consistent dexamethasone suppression test results with mania and depression in bipolar illness.
    Godwin CD; Greenberg LB; Shukla S
    Am J Psychiatry; 1984 Oct; 141(10):1263-5. PubMed ID: 6486264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone suppression test results in delusional versus nondelusional depression: preliminary evidence of distinct clinical entities.
    Kraus RP; Remick RA
    J Clin Psychiatry; 1985 May; 46(5):188-90. PubMed ID: 3988719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone suppression test as an aid for selection of specific antidepressant drugs in patients with endogenous depression.
    Rihmer Z; Arató M; György S; Révai K; Demeter E
    Pharmacopsychiatry; 1985 Sep; 18(5):306-8. PubMed ID: 4048265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothalamic-pituitary-adrenocortical function in geriatric depression: diagnostic and treatment implications.
    Georgotas A; Stokes PE; Krakowski M; Fanelli C; Cooper T
    Biol Psychiatry; 1984 May; 19(5):685-93. PubMed ID: 6733180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement.
    Holsboer F; Liebl R; Hofschuster E
    J Affect Disord; 1982 Jun; 4(2):93-101. PubMed ID: 6213695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normalisation of the dexamethasone suppression test: a correlate of clinical improvement in primary depressives.
    Bowie PC; Beaini AY
    Br J Psychiatry; 1985 Jul; 147():30-5. PubMed ID: 4063596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.